RecruitingNot ApplicableNCT06477640

Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension

Sponsor

University of Rochester

Enrollment

55 participants

Start Date

Jul 29, 2024

Study Type

INTERVENTIONAL

Conditions

Pulmonary Arterial Hypertension PAH

Summary

The purpose of this study is to evaluate whether a home rehabilitation program for patients diagnosed with Pulmonary Arterial Hypertension (PAH) will decrease Cardiac Effort (number of heart beats used during 6-minute walk test/walk distance) and improve quality of life. Ultimately, this information could help improve the management of patients with PAH.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a home-based exercise rehabilitation program can improve heart function in patients with pulmonary arterial hypertension (PAH) — a condition where blood pressure in the lung arteries is dangerously high, making the right side of the heart work too hard. **You may be eligible if...** - You are an adult (18+) seen at the University of Rochester Medical Center Pulmonary Hypertension Clinic - You have pulmonary hypertension confirmed by right heart catheterization - You have been on stable PAH medication for at least 30 days **You may NOT be eligible if...** - Your medication dosage is expected to change during the study - You have conditions that prevent safe exercise - You are unable to participate in a home-based program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALExercise

The intervention group will receive daily activity messages sent through SMS text message or email.The messages will provide daily exercises with heart rate guidance.

BEHAVIORALStandard of Care

The control group will receive daily non-descript messages to help with blinding and to eliminate the confounding variable of daily contact. The messages will not include activity tasks and will include phrases such as "I hope you have a good day".

Locations(1)

University of Rochester Medical Center

Rochester, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06477640

Related Trials

Study of Intravenous ZMA001 in Healthy Subjects

NCT059672991 location

Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)

NCT066585221 location